Kiersten L Strombotne1,2, Jessica Lum2, Nambi J Ndugga1,2, Anne E Utech3, Steven D Pizer1,2, Austin B Frakt1,2,4, Paul R Conlin2,5. 1. Department of Health Law, Policy and Management, Boston University of Public Health, Boston, Massachusetts, USA. 2. VA Boston Healthcare System, Boston, Massachusetts, USA. 3. Veterans Health Administration, Department of Veterans Affairs, Washington, District of Columbia, USA. 4. Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Cambridge, Massachusetts, USA. 5. Harvard Medical School, Boston, Massachusetts, USA.
Abstract
AIM: To test the effectiveness of a ketogenic diet and virtual coaching intervention in controlling markers of diabetes care and healthcare utilization. MATERIALS AND METHODS: Using a difference-in-differences analysis with a waiting list control group-a quasi-experimental methodology-we estimated the 5-month change in HbA1c, body mass index, blood pressure, prescription medication use and costs, as well as healthcare utilization. The analysis included 590 patients with diabetes who were also overweight or obese, and who regularly utilize the Veterans Health Administration (VA) for healthcare. We used data from VA electronic health records from 2018 to 2020. RESULTS: The ketogenic diet and virtual coaching intervention was associated with significant reductions in HbA1c (-0.69 [95% CI -1.02, -0.36]), diabetes medication fills (-0.38, [-0.49, -0.26]), body mass index (-1.07, [-1.95, -0.19]), diastolic blood pressure levels (-1.43, [-2.72, -0.14]), outpatient visits (-0.36, [-0.70, -0.02]) and prescription drug costs (-34.54 [-48.56, -20.53]). We found no significant change in emergency department visits (-0.02 [-0.05, 0.01]) or inpatient admissions (-0.01 [-0.02, 0.01]). CONCLUSIONS: This real-world assessment of a virtual coaching and diet programme shows that such an intervention offers short-term benefits on markers of diabetes care and healthcare utilization in patients with diabetes.
AIM: To test the effectiveness of a ketogenic diet and virtual coaching intervention in controlling markers of diabetes care and healthcare utilization. MATERIALS AND METHODS: Using a difference-in-differences analysis with a waiting list control group-a quasi-experimental methodology-we estimated the 5-month change in HbA1c, body mass index, blood pressure, prescription medication use and costs, as well as healthcare utilization. The analysis included 590 patients with diabetes who were also overweight or obese, and who regularly utilize the Veterans Health Administration (VA) for healthcare. We used data from VA electronic health records from 2018 to 2020. RESULTS: The ketogenic diet and virtual coaching intervention was associated with significant reductions in HbA1c (-0.69 [95% CI -1.02, -0.36]), diabetes medication fills (-0.38, [-0.49, -0.26]), body mass index (-1.07, [-1.95, -0.19]), diastolic blood pressure levels (-1.43, [-2.72, -0.14]), outpatient visits (-0.36, [-0.70, -0.02]) and prescription drug costs (-34.54 [-48.56, -20.53]). We found no significant change in emergency department visits (-0.02 [-0.05, 0.01]) or inpatient admissions (-0.01 [-0.02, 0.01]). CONCLUSIONS: This real-world assessment of a virtual coaching and diet programme shows that such an intervention offers short-term benefits on markers of diabetes care and healthcare utilization in patients with diabetes.
Authors: David Koot; Paul Soo Chye Goh; Robyn Su May Lim; Yubing Tian; Teng Yan Yau; Ngiap Chuan Tan; Eric Andrew Finkelstein Journal: JMIR Mhealth Uhealth Date: 2019-05-24 Impact factor: 4.773
Authors: Nasir H Bhanpuri; Sarah J Hallberg; Paul T Williams; Amy L McKenzie; Kevin D Ballard; Wayne W Campbell; James P McCarter; Stephen D Phinney; Jeff S Volek Journal: Cardiovasc Diabetol Date: 2018-05-01 Impact factor: 9.951
Authors: Mark A Berman; Nicole L Guthrie; Katherine L Edwards; Kevin J Appelbaum; Valentine Y Njike; David M Eisenberg; David L Katz Journal: JMIR Diabetes Date: 2018-02-14
Authors: Amy L McKenzie; Sarah J Hallberg; Brent C Creighton; Brittanie M Volk; Theresa M Link; Marcy K Abner; Roberta M Glon; James P McCarter; Jeff S Volek; Stephen D Phinney Journal: JMIR Diabetes Date: 2017-03-07